Showing results (191-200 of 202) with videos related to

Sort By:
Pageof 21
Blood Cancer Discovery|May 20, 2026
RAS pathway activation and microenvironmental adaptation as hallmarks of myeloid sarcomaBettina Nadorp, Audrey Lasry, Sanam Loghavi, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2026
Multiomic characterization, early detection, and therapeutic targeting of myeloid sarcomaBettina Nadorp, Audrey Lasry, Sanam Loghavi, et al.
British Journal of Haematology|July 31, 2025
Grandchildren of GRNDaD: Shifts in disease-modifying therapy at the adolescent transition in sickle cell diseaseMatthew Chang, Daniel Semakula, Jane A Little, et al.
Human Mutation|July 23, 2021
SLC25A38 congenital sideroblastic anemia: Phenotypes and genotypes of 31 individuals from 24 families, including 11 novel mutations, and a review of the literatureMatthew M Heeney, Simon Berhe, Dean R Campagna, et al.
Pediatric Blood & Cancer|April 14, 2023
Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective studyPhilipp R Aldana, Ricardo A Hanel, Joseph Piatt, et al.
Blood Advances|December 22, 2020
Safety and efficacy of rivaroxaban in pediatric cerebral venous thrombosis (EINSTEIN-Jr CVT)Philip Connor, Mayte Sánchez van Kammen, Anthonie W A Lensing, et al.
MMWR. Morbidity and Mortality Weekly Report|September 14, 2018
Sentinel Surveillance for Congenital Rubella Syndrome - India, 2016-2017Manoj Murhekar, Ashish Bavdekar, Asha Benakappa, et al.
Plos Neglected Tropical Diseases|February 4, 2020
Epidemiology of Congenital Rubella Syndrome (CRS) in India, 2016-18, based on data from sentinel surveillanceManoj Murhekar, Sanjay Verma, Kuldeep Singh, et al.
Blood Advances|July 2, 2026
Pediatric autoimmune hemolytic anemia is associated with a high incidence of underlying immune disordersEmily M Harris, MacGregor Steele, Tatiana Kalashnikova, et al.
BMC Endocrine Disorders|May 21, 2026
Real-world evidence of urinary tract infections and genital tract infections with sodium-glucose cotransporter-2 inhibitors (SGLT2i) alone or in combination with dipeptidyl peptidase-4 inhibitors (DPP4i) in individuals with type-2 diabetes mellitus in IndiaNagendra Kumar Singh, Akash Kumar Singh, Arvind Gupta, et al.
Pageof 21